Physician profile
Daniel Sacks
NPI 1598059545
$6,071.25
in general payments reported to CMS, 2019-2025
27 companies · $815 in 2025
The $815 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,606 · 2020: $512 · 2021: $276 · 2022: $546 · 2023: $467 · 2024: $1,850 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,242 · Travel and Lodging: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,241.64 |
| Travel and Lodging | $890.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,369.71 | 2024 | |
| Inspire Medical Systems, INC. | $1,194.88 | 2019-2025 | Inspire |
| Stryker Corporation | $914.80 | 2019-2022 | |
| Intersect Ent, INC. | $470.73 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $424.82 | 2022-2025 | Dupixent, Libtayo |
| Optinose US, INC. | $304.12 | 2020-2025 | |
| Cochlear Americas | $249.34 | 2019-2024 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Integra Lifesciences Corporation | $217.32 | 2019-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Glaxosmithkline, LLC. | $184.36 | 2021-2025 | Nucala |
| Gt Medical Technologies, INC | $134.71 | 2023 | Gammatile |
| Genzyme Corporation | $106.30 | 2022-2025 | |
| Hikma Pharmaceuticals USA | $58.19 | 2023-2025 | Ryaltris |
| Novartis Pharmaceuticals Corporation | $45.09 | 2019 | |
| Merck Sharp & Dohme LLC | $44.07 | 2022-2025 | Keytruda |
| Genentech USA, INC. | $38.46 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $38.09 | 2021-2024 | Propel |
| Alk-Abello, INC | $37.81 | 2020 | |
| Olympus America INC. | $35.55 | 2019-2022 | |
| Hologic Sales and Service, LLC | $32.23 | 2024 | Coolseal Generator |
| Smith+Nephew, INC. | $28.48 | 2024 | Tula |
| Kaleo, INC. | $25.57 | 2023 | Auvi-Q |
| Neurent Medical Limited | $24.78 | 2022 | |
| Ethicon US, LLC | $21.91 | 2019 | |
| Galderma Laboratories, L.P. | $20.73 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $19.73 | 2025 | Neffy |
| Lilly USA, LLC | $15.41 | 2025 | Zepbound |
| Astrazeneca Pharmaceuticals Lp | $14.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sacks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.